TRIMEDX has released its 2026 industry report on clinical asset management, From possibility to performance: How health systems can operationalize AI, strengthen resilience, and lead through change, ...

YoY Growth in Revenue, Earnings, and Cash Flow Increased Adjusted Diluted EPS Outlook for Completed Share Repurchases Executing on Capital ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report first quarter 2026 financial results and provide a ...

Reiterates revenue guidance for fiscal year 2026 Executed on stock repurchase program; purchased approximately 2.6 million shares in the first quarter of 2026 using $40.1 million in cash Revenue of ...

Global Net Rooms Increased 1.7%, with U.S. Net Rooms Growth ImprovingQ1 U.S. Hotel Openings Hit Five-Year High Global Franchise Agreements Awarded Increased 72% NORTH BETHESDA, Md., April 30 ...

NewcelX and Eledon Pharmaceuticals are collaborating to advance one of the few scalable approaches to a potential functional cure in Type 1 Diabetes, NCEL-101, as the flagship program and key ...

Company Announces a Record Year of Results for 2025 with Strong Momentum Across Strategic Priorities and Key Financial ...

PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the 'Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported ...

Delivering Strong Sales Volume Growth Reaffirming Full-Year Volume and Cost Expectations Executing Pricing Actions and Other ...

All reported figures in U.S. Dollars unless otherwise noted Boston, MA, April 27, 2026 (GLOBE NEWSWIRE) -- MiniLuxe Holding Corp. (TSXV: MNLX) today announced its financial results for the 52 weeks ...

Not for Distribution to United States Wire Services or Dissemination in the United States TORONTO, ON / ACCESS Newswire ...